Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
An association has been previously established between uncompensated diabetes mellitus and the loss of bone mineral density and/or quality. In this study, we evaluated the effects of metformin on the growth and differentiation of osteoblasts in culture. Treatment of two osteoblast-like cells (UMR106...
Guardado en:
| Autores principales: | Cortizo, Ana María, Sedlinsky, Claudia, McCarthy, Antonio Desmond, Blanco, Alcira, Schurman, León |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2006
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/76260 |
| Aporte de: |
Ejemplares similares
-
Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy?
por: McCarthy, Antonio Desmond, et al.
Publicado: (2016) -
Efectos <i>in vivo</i> del ranelato de estroncio sobre células progenitoras de médula ósea de ratas diabéticas
por: Lino, Agustina Berenice, et al.
Publicado: (2016) -
Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment
por: Felice, Juan Ignacio, et al.
Publicado: (2017) -
Opposing effects of bisphosphonates and advanced glycation end-products on
osteoblastic cells
por: Gangoiti, María Virginia, et al.
Publicado: (2008) -
Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin
por: Tolosa, María José Anahí, et al.
Publicado: (2013)